Abstract
This study compares inducibility of ventricular tachyarrhythmias by programmed electrical stimulation of the heart in patients with myocardial infarction with and without reperfusion after streptokinase therapy. Sixty-two consecutive patients admitted with an acute myocardial infarction were randomized to either combined intravenous and intracoronary streptokinase (streptokinase group) or to standard coronary care unit treatment (control group). Thirty-six of the 62 patients (21 patients from the streptokinase and 15 from the control group) with a first myocardial infarction were studied by programmed ventricular stimulation after a mean of 26 ± 14 days. No patient had a history of antiarrhythmic drug use or documentation of a ventricular arrhythmia before the initial admission.
A sustained ventricular arrhythmia was induced in 10 (48%) of the 21 patients randomized to streptokinase therapy and in all 15 (100%) control patients (p < 0.001). Sustained monomorphic ventricular tachycardia was induced in 6 (29%) and 10 (67%) patients, respectively (p < 0.05). To terminate an induced tachycardia, direct current countershock was required in 33% of patients in the streptokinase group and 73% of patients in the control group (p < 0.02). Seventeen of the 21 patients treated with streptokinase and no control patient had evidence of early reperfusion 200 ± 70 min after the onset of pain. In comparison with patients without early reperfusion, patients in the reperfused group had a lower maximal serum creatine kinase value (p < 0.01), a shorter time to peak creatine kinase value (p < 0.001) and a higher angiographic left ventricular ejection fraction (62 versus 45%, p < 0.01). Induction of sustained monomorphic ventricular tachycardia correlated with absence of early reperfusion (sensitivity 74%, specificity 88%, positive predictive value 88%) and a low angiographic left ventricular ejection fraction (<40%) (p < 0.02). No correlation was found between induction of ventricular arrhythmias by programmed electrical stimulation and the occurrence of Lown class 4b ventricular arrhythmias. After a mean follow-up period of 14 months, no patient suffered from a symptomatic arrhythmia and one control patient died.
Sustained ventricular arrhythmias are less commonly induced in patients with early reperfusion by thrombolytic agents than in patients without reperfusion. Results of programmed stimulation 4 weeks after myocardial infarction do not predict survival, but are related to the extent of myocardial damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wellens HJJ, Schuilenburg RM, Durrer D: Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 46: 216–226, 1972.
Fisher JD, Cohen HL, Mehra R, Altschuler H, Escher DJW, Furman S: Cardiac pacing and pacemakers. II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J 93: 658–668, 1977.
Josephson ME, Horowitz LN: Electrophysiologic approach to the therapy of recurrent sustained ventricular tachycardia. Am J Cardiol 43: 631–642, 1979.
Mason JW, Winkle RA: Accuracy of the ventricular tachycardia induction study for predicting long-term efficiency and inefficiency of anti-arrhythmic drugs. N Engl J Med 303: 1073–1077, 1980.
Josephson ME, Horowitz LN, Spielman SR, Greenspan AM: Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest. Am J Cardiol 46: 948–955, 1980.
Ruskin JN, Di Marco JP, Garan H: Out-of-hospital cardiac arrest: electrophysiologic observations and selection of longterm antiarrhythmic therapy. N Engl J Med 303: 607–613, 1980.
Greene HL, Reid PR, Schaeffer AH: The repetitive ventricular response in man. A predictor of sudden death. N Engl J Med 299: 729–734, 1978.
Kowey PR, Folland ED, Parisi AF, Lown B: Programmed electrical stimulation of the heart in coronary artery disease. Am J Cardiol 51: 531–536, 1983.
Richards DA, Cody DV, Denniss AR, Russell PA, Young AA, Uther JB: Ventricular electrical instability: a predictor of death after myocardial infarction. Am J Cardiol 51: 75–80, 1983.
Hamer A, Vohra J, Hunt D, Sloman G: Prediction of sudden death by electrophysiologic studies in high risk patients surviving acute myocardial infarction. Am J Cardiol 50: 223–229, 1982.
Smalling RW, Fuentes F, Matthews MW et al.: Sustained im-provement in left ventricular and mortality by intracoronary streptokinase administration during evolving myocardial infarction. Circulation 68: 131–138, 1983.
Kennedy JW, Ritchie JL, Davis KB, Fritz JK: Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 309: 1477–1482, 1983.
Rentrop KP, Cohen M, Hosat ST: Thrombolytic therapy in acute myocardial infarction: review of clinical trials. Am J Cardiol 54: 29–31, 1984.
Rentrop KP, Feit F, Blanke H et al.: Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med 311: 1457–1463, 1984.
Malacoff R, McGovern B, Ruskin J et al.: Ventricular electrical instability in patients treated with streptokinase during acute myocardial infarction (abstr). J Am Coll Cardiol 1: 604, 1983.
McComb JM, McGovern B, Gold HK, Leinbach RC, Ruskin JN, Garan H: Programmed cardiac stimulation in patients treated with recombinant tissue plasminogen activator (abstr). Circulation 70(suppl II): 155, 1984.
The Multicenter Postinfarction Research Group: Risk stratification and survival after myocardial infarction. N Engl J Med 309: 331–336, 1983.
Lown B, Wolf M: Approaches to sudden death from coronary heart disease. Circulation 44: 130–142, 1971.
Brugada P, Green M, Abdollah H, Wellens HJJ: Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of arrhythmia induced and the number of premature stimuli required. Circulation 69: 87–92, 1984.
Brugada P, Abdollah H, Heddle B, Wellens HJJ: Results of a ventricular stimulation protocol using a maximum of 4 premature stimuli in patients without documented or suspected ventricular arrhythmias. Am J Cardiol 52: 12114–12118, 1983.
Austen WG, Edwards JE, Frye RL et al.: A reporting system on patients evaluated for coronary artery disease. Circulation 51: 5–40, 1975.
Buxton AE, Waxman HL, Marchlinsky FE, Untereker WJ, Waspe LE, Josephson ME: Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation 69: 532–540, 1984.
Vandepol CJ, Farshidi A, Spielman SR, Greenspan AM, Horowitz LN, Josephson ME: Incidence and clinical significance of induced ventricular tachycardia. Am J Cardiol 45: 725–731, 1980.
Livelli FD, Bigger JT, Reiffei JA et al.: Response to programmed ventricular stimulation: sensitivity, specificity and relation to heart disease. Am J Cardiol 50: 452–458, 1982.
Mann DE, Luck JC, Griffin JC et al.: Induction of clinical ventricular tachycardia using programmed stimulation: value of third and fourth extrastimuli. Am J Cardiol 52: 501–506, 1983.
Marchlinsky FE, Buxton AE, Waxman HL, Josephson ME: Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction. Am J Cardiol 52: 1190–1196, 1983.
Morady F, Shapiro W, Shen E, Sung RJ, Scheinman MM: Pro-grammed ventricular stimulation in patients without spontaneous ventricular tachycardia. Am Heart J 107: 875–882, 1984.
Brugada P, Waldecker B, Wellens HJJ: Characteristics of induced ventricular arrhythmias in four subgroups of patients with myocardial infarction (abstr). Circulation 70(suppl II): 19, 1984.
Santarelli P, Bellocci F, Loperfido F et al.: Ventricular arrhythmia induced by programmed ventricular stimulation after acute myocardial infarction. Am J Cardiol 55: 391–394, 1985.
Roy D, Marchand E, Theroux P, Waters DD, Pelletier GB, Bourassa MG: Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation 72: 487–494, 1985.
Moss AJ, DeCamilla J, Davis H: Cardiac death in the first 6 months after myocardial infarction: potential for mortality reduction in the early posthospital period. Am J Cardiol 39: 816–820, 1977.
Taylor GJ, Humphries JO, Mellits ED et al.: Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 62: 960–970, 1980.
De Feyter PJ, van Eenige MJ, Digthon DH, Visser FC, de Jong J, Roos JP: Prognostic value of exercise testing, coronary angiography and left ventriculography 6-8 weeks after myocardial infarction. Circulation 66: 527–536, 1982.
Wilber DJ, Lynch JJ, Montgomery D, Lucchesi BR: Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. Am Heart J 109: 8–18, 1985.
Karagueuzian HS, Fenoglio JJ, Weiss MB, Wit AL: Protracted ventricular tachycardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. Circ Res 44: 833–846, 1979.
Anderson JL, Marshall HW, Bray BE et al.: A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 308: 1312–1318, 1983.
Bonow RO, Lipson LC, Sheehan FH et al: Lack of effect of aspirin on myocardial infarct size in the dog. Am J Cardiol 47: 258–263, 1981.
Vogel WM, Zannoni VG, Abrams GD, Lucchesi BR: Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog. Circulation 5: 588–595, 1977.
Anderson JL, Marshall HW, Askins JC et al.: A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation 70: 606–618, 1984.
Anderson JL, McIlvaine PM, Marshall HW et al.: Long-term follow-up after intracoronary streptokinase for myocardial infarction: a randomized, controlled study. Am Heart J 108: 1402–1408, 1984.
Khaja F, Walton JA Jr, Brymer JF et al.: Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med 308: 1305–1311, 1983.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kersschot, I.E. et al. (2000). Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: A prospective, randomized study. In: Smeets, J.L.R.M., Doevendans, P.A., Josephson, M.E., Kirchhof, C., Vos, M.A. (eds) Professor Hein J.J. Wellens. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4110-9_35
Download citation
DOI: https://doi.org/10.1007/978-94-011-4110-9_35
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5799-8
Online ISBN: 978-94-011-4110-9
eBook Packages: Springer Book Archive